GEN has retained its position as the number one biotech publisher around the globe since its launch in 1981, with a print edition, additional content online, and a networking platform, GENconnect. Thu, 17 May 2012 14:13:34 -0400 http://www.genengnews.com/media/files/rss/TRANSLATIONAL-MEDICINE-biosimilars.xml http://www.genengnews.com/industry-updates/immune-deficiency-foundation-urges-fda-to-exempt-immunoglobulin-from-biosimilars-pathway/151137652/ http://www.genengnews.com/industry-updates/immune-deficiency-foundation-urges-fda-to-exempt-immunoglobulin-from-biosimilars-pathway/151137652/ Wed, 16 May 2012 14:30:00 -0400